P1533: TRIAL IN PROGRESS: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 3 STUDY OF THE EFFICACY AND SAFETY OF PARSACLISIB IN PATIENTS WITH PRIMARY WARM AUTOIMMUNE HEMOLYTIC ANEMIA
W. Barcellini,
K. Butler,
S. Moran,
K. Bibeau,
I. Dzhindzhikhashvili,
S. Wei,
U. Jäger
Affiliations
W. Barcellini
1 Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy
K. Butler
2 Incyte Corporation, Wilmington, DE, United States of America
S. Moran
2 Incyte Corporation, Wilmington, DE, United States of America
K. Bibeau
2 Incyte Corporation, Wilmington, DE, United States of America
I. Dzhindzhikhashvili
2 Incyte Corporation, Wilmington, DE, United States of America
S. Wei
2 Incyte Corporation, Wilmington, DE, United States of America
